China Resources Sanjiu: Some medicines are proposed to be selected in the 12th batch of national drug procurement, with the procurement period extending to the end of 2029.

China Resources Double Crane announced that the company and some of its subsidiaries will participate in the twelfth round of national centralized drug procurement bidding. The products proposed for selection include Amlodipine Benazepril Capsules, Paliperidone Extended-Release Tablets, Vitamin B6 Injection, Doxazosin Mesylate Extended-Release Tablets, Sacubitril/Valsartan Tablets, Perindopril/Amlodipine Tablets, and Buprenorphine Tablets. The procurement period will be from the date of the selection results until December 31, 2029.